Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
Investment builds on almost 140-year legacy of improving and saving lives and supporting American jobs Includes four planned new manufacturing...
Pharmaceutical
Genmab, NHS England, Pistoia Alliance and Regeneron Win Bio-IT World Innovative Practices Awards
Organizations to be Featured During Friday Sessions ofBio-IT World Conference & Expo, April 2-4 in Boston BOSTON, March 21, 2025...
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington
TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology...
Cosmo Pharmaceuticals publishes Annual Report 2024
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - March 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX:...
Trua Senior Living Locators of Raleigh Set to Help Local Families Match Ideal Senior Care
RALEIGH, N.C., March 20, 2025 /PRNewswire/ -- Trua Senior Living Locators – a fast-growing national franchise that helps families find...
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare OpportunitiesYONGIN,...
Elevate Health Technologies’ Pulse AI Software is Driving Improved Patient Care and Operational Efficiency at Heart South Cardiovascular Group
HOUSTON, March 20, 2025 /PRNewswire/ -- Elevate Health Technologies announced that its Pulse AI software for medical practices is being used...
Life Sciences and Nutrition Luminary Dr. Rob Sinnott joins Radicle Science as Senior Strategic Advisor
Addition Bolsters Healthtech Pioneer's Innovation Trajectory; Accelerates Growth, Diversifies Offerings and Expands Global Reach SAN DIEGO, March 20, 2025 /PRNewswire/...
Sibel Health Announces Close of New Series C Financing and New FDA 510(k) Clearance
Sibel Health announces the close of new $30 million dollar Series C financing round led by the Steele Foundation for...
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
$10 Million Acquisition Bolsters FITY's Leadership with Dr. Gennaro D'Urso as CEO and ChairmanMELBOURNE, Fla., March 20, 2025 (GLOBE NEWSWIRE)...
Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer
Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of...
Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is a clinical decision support system used by more...
TOMI Environmental Solutions Selected by NASA for Biosecurity Operation
FREDERICK, Md., March 20, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection...
Universe Pharmaceuticals INC Announces Share Consolidation
Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical...
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in CanadaLONDON...
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights
Achieved Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue...
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on cardiovascular diseases with high...
Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma
Data to be presented in oral session and poster at the 16th Annual T-Cell Lymphoma ForumSOUTH SAN FRANCISCO, Calif., March...
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
OREM, Utah, March 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC: RSCF), a leading provider of cryogenic cooling and...